Arkansas bought execution drugs from British company that banned state’s use

Arkansas, which plans to resume lethal injections next month, has avoided Hikma Pharmaceuticals’ inquiries, citing new secrecy law on execution policies

A British pharmaceutical company that told Arkansas not to use its products during executions is trying to determine if the state plans to use them anyway, but prison officials are dismissing inquiries about the drug by citing a new law that makes all execution policies an official state secret.

Hikma Pharmaceuticals canceled a contract with Arkansas prison officials in 2013, after it learned the state purchased a seizure medication and another drug to use in lethal injections from one of its US subsidiaries.

Related: Appeals court halts Oklahoma man’s execution amid new doubts over guilt

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks


© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us